ArticleBMJ open quality2023
Endorsing: closing the loop on diagnostic tests in electronic health care records.
Article in BMJ open quality, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Oxford University Hospital NHS Trust (OUH) had introduced a policy to improve the timely endorsement of diagnostic tests. However, performance in the Oxford Kidney Unit (OKU) has been consistently below the OUH target of 85%. This project was undertaken to improve endorsement within the OKU. Weekly percentages of all diagnostic test results that were endorsed within 7 days of reporting were monitored as our main outcome measurement. During the intervention period, four plan-do-study-act (PDSA) cycles were undertaken each lasting 6 weeks. Introduced changes included interventions to develop a team-based approach and practical tools to enhance compliance, such as creating clinical worklists, a guidance document on endorsement and an endorsement newsletter. Data was monitored for a further 6 months beyond the intervention period to ensure improvement was sustained. There was a significant improvement in endorsement to above 85% by the end of the second PDSA cycle. This was maintained throughout the project and for a further 6 months beyond the intervention period. Our systematic approach to improving the endorsement of results is potentially transferable to other healthcare organisations using electronic healthcare records for clinical care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.